The Global Tax Head will be responsible for providing international tax planning and strategic leadership of the tax function. As the worldwide leader of our tax organization, you will establish the department’s vision and goals. The Global Tax Head is skillful in developing world-wide tax planning strategies, analyzing issues and communicating and collaborating with cross-functional business partners with varying backgrounds and levels of experience. This role currently includes tax operations within the Americas, China, Europe and Asia. This position will report to the Global Controller. The role is based in Shanghai (can also expand to other cities if we cannot find a candidate in Shanghai)
Job Duties and Responsibilities:
Includes all duties of the Global Tax Head
Establish and maintain readiness for future Initial Public Offering (IPO)
Job Requirements:
Bachelor’s degree in Tax, Finance, Accounting, or related field
CPA or equivalent required;
8+ years of experience as CN/US and international tax experiences or equivalent.
3+ years of relevant work experience in a global company in leading a tax organization.
Relevant experience in CRO or Life Sciences is preferred
Big 4 experience a plus
oExtensive China / U.S. Federal, State and International income tax and transaction tax knowledge, including a working knowledge of transfer pricing.
oOrganizational skills and the ability to maintain information in a logical manner.
·Capabilities
oAbility to adapt to changes in priorities.
oAbility to be results oriented and exhibit a high degree of creativity, energy, and resourcefulness.
oAbility to translate and communicate complex tax issues to an audience of non-finance professionals.
oAbility to travel domestically and internationally if required.
oAbility to maintain regular and predictable attendance.
oAbility to work in a constant state of alertness.

Caidya is a multi-therapeutic clinical research organization (CRO) serving innovators worldwide. Focused on delivery excellence and an elevated customer experience, Caidya offers a wide range of clinical services and vast therapeutic expertise, supporting its partners from pre-IND strategy, through clinical development to submission and post-marketing surveillance.
Caidya leverages industry-leading and proprietary clinical technology to ensure trial transparency and data-driven decision-making. Formed in 2021 following the combination of leading CROs, dMed and Clinipace, Caidya has nearly 1,800 employees in more than 30 countries throughout the world.